Objectives: Factors potentially contributing to fluoroquinolone resistance selection in commensal Escherichia coli strains in poultry were studied through a series of in vivo experiments. The effect of the initial prevalence of enrofloxacin resistance in the E. coli gut microbiota, effect of the bacterial fitness of the enrofloxacin-resistant strain and effect of treatment with enrofloxacin (effect of dose and effect of route of administration) were assessed.
Introduction
Antimicrobial resistance is a natural phenomenon dating back thousands of years before the use of antimicrobials by humans. 1, 2 Nevertheless, the use of antimicrobials has contributed to the rise of antimicrobial resistance in bacterial pathogens of human and veterinary importance. [3] [4] [5] Fluoroquinolones constitute a critically important class of antimicrobial agents that directly inhibit DNA replication and transcription. In veterinary medicine, fluoroquinolones are widely used, particularly in broiler production, 6 with the oral route being the preferred administration route. Despite their efficacy, the use of fluoroquinolones in veterinary medicine is controversial. 7 Concerns about the increasing resistance to enrofloxacin in poultry led to the withdrawal of its use in 2005 in the USA, 8 while in Australia its use has never been authorized. Nonetheless, in two later studies from USA 9 and Australia, 10 fluoroquinoloneresistant strains were detected in several broiler samples, prompting the authors to suggest either a non-proper enforcement of the ban, 9 or co-selection caused by the use of other antimicrobial agents. 10 Several studies have suggested a link between oral treatment with antimicrobial agents and selection of antimicrobial resistance in chickens. [11] [12] [13] [14] Nevertheless, only a few studies compare parenteral and oral treatment protocols in broilers, and they focus solely on the pharmacokinetics of enrofloxacin and not on its effect on resistance selection. 15, 16 If the effect of all contributing factors could be quantified, the treatment regimen (dose, route of administration, duration) could be improved to reduce resistance selection while maintaining clinical efficacy.
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Antibiotic resistance mechanisms can cause a fitness cost to the bacterium. This cost is more considerable in chromosomal resistance mutations than in resistance acquired via horizontal gene transfer. 17 This cost is a key parameter in the spread and persistence of antimicrobial-resistant bacteria. 18 However, it is not yet known to what extent fitness influences resistance selection. Studies supporting the reversibility of antibiotic resistance through minimizing antimicrobial use are available, [19] [20] [21] [22] [23] though other studies focus on concepts such as compensatory evolution and genetic co-selection that make reversibility less probable (even if a fitness cost is present) in real-life settings. [24] [25] [26] The potential for reversing antibiotic resistance through the reduction of antibiotic use will be dependent on the fitness cost of the resistance mechanism, epidemic potential of the bacteria and transmission route of the species. 27 Overall, there is insufficient information on the epidemiology of antimicrobial resistance, and this lack hampers efforts to provide appropriate and specific advice on measures that might reduce risks of resistance selection. In response, the present study aims at quantifying the effects of different factors on fluoroquinolone resistance in commensal E. coli in broilers, using well-defined and controlled experimental in vivo models. Four in vivo experiments were designed to study the influence of the: (i) prevalence and (ii) fitness of enrofloxacin-resistant strains in the early (1 day old) E. coli gut microbiota, (iii) treatment dose and (iv) route of administration of enrofloxacin on fluoroquinolone resistance selection in commensal E. coli.
Materials and methods

Ethics
In vivo experiments were compliant with all relevant institutional and European standards for animal care and experimentation. All experiments were approved by the Ethics Committee of the Faculty of Veterinary Medicine, Ghent University (EC2014/141, EC2015/33, EC2015/34, EC2015/61).
Bacterial strains
The E. coli IA2 strain was obtained from a faecal sample of a healthy broiler chicken. The isolate was confirmed as being E. coli, and after being serotyped with the following monospecific antisera against 24 different somatic  O antigens: O1, O2, O5, O6, O8, O9, O11, O12, O14, O15, O17, O18, O20,  O35, O36, O45, O53, O78, O81, O83 , O102, O103, O115 and O116, it was deemed to be non-serotypable (identified and serotyped by CODA CERVA, Uccle, Belgium). Moreover, the strain was susceptible to all tested antibiotics (Table S1 , available as Supplementary data at JAC Online). On top of that, no plasmid-mediated quinolone resistance (PMQR) genes were detected after using a protocol described by Robicsek et al. 28 to detect any qnrA, qnrB and qnrS determinants and by Park et al. 29 to detect the aac(6 0 )-lb-cr determinant.
Using this strain, a spontaneous rifampicin-resistant mutant strain (E. coli IA31) was derived as previously described. 30 Using IA31 and the same technique, a bacteriologically non-fit (E. coli IA50) enrofloxacinresistant strain and a bacteriologically fit (E. coli IA66) enrofloxacinresistant strain were created (Table 1) . Bacterial fitness was assessed with in vitro growth competition assays between the resistant strain and the parental susceptible strain. 24 Equal densities of the enrofloxacinsusceptible and -resistant strain were mixed and incubated in antibioticfree LB medium. Every 24 h, 0.05 mL of the overnight culture was inoculated into 5 mL of new LB medium for growth. Aliquot parts of the same volume were plated, via a spiral plating technique, every 24 h onto drug-free McConkey agar to count the number of colonies and onto McConkey agar plates containing 1 mg/L enrofloxacin to count the number of enrofloxacin-resistant strains. The number of parental enrofloxacinsusceptible colonies was calculated as the total number of bacterial cells minus the number of drug-resistant bacterial cells. The relative fitness was calculated as described. 31 All experiments were performed in triplicate with three independent cultures and a weighted mean was used for analysis.
The MIC, MBC and mutant prevention concentration (MPC) for the reference and resistant strains were determined as previously described. [32] [33] [34] [35] E. coli ATCC 25922V C was used as a control strain for the in vitro tests.
PCR amplification and DNA sequence analysis
For the PCR amplification and sequencing of gyrA, gyrB, parC and parE genes, the respective primers were used [36] [37] [38] (Table S2 ). The amplification protocol was performed with a MasterCycler Gradient EP-S Thermal Cycler (Eppendorf AG, Hamburg, Germany). The PCR products for strains IA31, IA50 and IA66 were sequenced (Eurofins Genomics GmbH, Ebersberg, Germany) and the nucleotide sequences obtained were analysed for the presence of point mutations in the quinolone resistance-determining regions using the BLAST search engine and the ClustalW multiple alignment tool 39 ( Table 2 ).
In vivo trials
Eggs, chickens, housing and welfare Embryonated 17 day old eggs were collected under aseptic conditions from a commercial poultry hatchery (Vervaeke-Belavi, Belgium). The eggs were disinfected with a gas formaldehyde mixture at the hatchery, but after transportation, they were additionally dipped in 5% H 2 O 2 for 10-15 s. After drying for 20-25 s, they were further incubated in three separate sanitized hatching cabinets. Each cabinet was placed in a separate decontaminated stable.
As soon as the chicks were hatched, they were orally inoculated (Table 1 ) and subsequently housed in groups (each group consisting of five chicks) in 1 m 2 disinfected boxes in HEPA-filtered stables. Nine groups were used in each experiment and in total, 180 chickens were used in this study (45 per experiment) . The birds received 16 h of light daily, and had free access to autoclaved food and bottled water. Each bird was individually numbered. All birds were clinically examined on a daily basis and any clinical signs of disease were registered. Euthanasia was performed by intravenous injection with an overdose (10 mg/kg) of sodium pentobarbital 20% (Kela, Hoogstraten, Belgium).
Experimental set-up
As soon as the chickens were hatched, they were all inoculated with a specific bacterial inoculum in accordance with the experiment performed ( Table 1 ). The experimental set-up, treatment and sampling procedure was identical for all experiments ( Figure 1 ). All necessary biosecurity measures were taken to avoid any cross-contamination (feed, water, indirect contact, airborne transmission) between groups. Each stable contained a control group (non-treated animals), a group that was treated with enrofloxacin (Baytril TM 2.5% injectable solution; Bayer AG, Leverkusen, Germany) intramuscularly and a group that received enrofloxacin via drinking water (Baytril TM 10% oral solution; Bayer AG). Water was provided ad libitum. Treatment period lasted 3 days (days 6-8). Treatment doses (Table S3) were calculated based on the daily average body weight and the average water consumption, 40 although water intake was not measured in detail.
In total, six faecal samplings took place in each experiment. Starting from day 3 of the experiment, there was one sampling every 3 days until day 15. Then, one additional sampling took place right before euthanasia on day 22. Each sample was collected from a single animal and consisted Chantziaras et al.
of $1 g of faecal content. Upon collection, all fresh individual samples were placed in sterile tubes and immediately transported to the laboratory for bacteriological enumeration.
Bacteriological enumeration in faecal samples
The faecal content was serially 10-fold diluted in phosphate-buffered saline solution (10
). The spiral plating technique was used to enumerate the E. coli population (Eddy Jet; IUL Instruments, Barcelona, Spain).
All serial dilutions were plated on both (i) rifampicin-supplemented (100 mg/L) McConkey agar plates, and (ii) enrofloxacin-supplemented (0.25 mg/L) and rifampicin-supplemented (100 mg/L) McConkey agar plates. Since the enrofloxacin-susceptible strain cannot grow on the enrofloxacinsupplemented plates, these plates were used to differentiate the inoculated strains and allow for the calculation of the ratio of resistant strains.
After the inoculation of each plate, they were placed in an incubator set at 37.0+1
C and examined after 24+3 h for the presence of typical colonies of E. coli. The colonies per plate were counted on plates ideally having 20-200 colonies per plate and the number of cfu/g of faeces was calculated. In the exceptional case where less than five colonies per plate were counted in the lowest dilution, the sample was omitted.
Statistical analysis
In all the following analyses, linear mixed models were used (SPSS Statistics for Windows, version 23.0; IBM Corp., Armonk, NY, USA). Each animal was listed as 'subject', and the sampling as 'repeat'. An autoregressive covariance matrix of the first order was used for the repeated covariance structure. To correct for the interdependency of chicks within a given pen, 'pen' was included as a random variable. The dependent variable used was the ratio of the number of enrofloxacin-resistant colonies to the total number of retrieved E. coli.
Assessment of treatment
The proportion of resistant strains over time was compared between animals that received treatment and those that did not. Observations for days For all inocula, the volume (dose per animal) was 0.2 mL and the concentration (cfu/mL inoculum) was $10 8 cfu/mL. Fluoroquinolone resistance in E. coli in poultry JAC Assessment of prevalence (inoculum ratio), fitness of enrofloxacin-resistant strains, treatment dose and route of administration All animals that received treatment were included in the model. The fixed factors that were studied were the following: inoculum ratio (highly resistant, highly susceptible), bacteriological fitness (fit, non-fit), treatment dose (proper-, half-, double-treatment schemes) and route of enrofloxacin administration [oral, parenteral (intramuscular)]. All potential fixed factors were first tested univariately. Only variables with a P , 0.2 were selected to be included in a mixed (multivariate) linear model. The model was built according to a stepwise forward selection procedure. In the final mixed linear model, two-way interactions between significant variables were also evaluated. The main effects from the fixed factors were compared and Bonferroni correction was used to adjust confidence intervals. Throughout the entire analysis, the significance level was set at P 0.05.
Results and discussion
In vitro characterization of strains
The DNA sequencing results of the quinolone resistancedetermining regions of gyrA, gyrB, parC and parE are shown in Table  2 . The reference strain showed no codon mutations resulting in amino acid changes when compared with E. coli ATCC 25922. For gyrA, two point mutations at codons 83 and 87 took place in both IA50 and IA66 when compared with the IA31 strain. Furthermore, for parC, a mutation at codon 78 occurred in the non-fit isolate, whereas a mutation at codon 80 in the fit strain was seen. In various studies, [41] [42] [43] [44] [45] [46] mutations in parC accompanied the mutations from gyrA in the vast majority of the clinically resistant isolates that were tested. In these studies, the predominant mutation in parC was found in codon 80, accompanied in some isolates by a mutation in codon 84. When comparing the strains in these studies with the strains of this paper, the fit strain had a mutation in codon 80, while the mutation in the non-fit strain occurred in codon 78. To the authors' knowledge, only two strains with a mutation in codon 78 (for parC) have been reported previously in the literature, 45, 47 and for IA50, the exact combination of codon changes here reported is described for the first time. It is not clear whether these mutations could be linked with the strain's inferior bacterial fitness. 48 In an in vitro study in which the fitness of isogenic resistant strains was assessed, 49 the strains with similar mutations to IA66 were also found to be bacteriologically fit when compared with their parental strains.
The enrofloxacin MICs of the isogenic resistant strains were both 32 mg/L, and for the (parental) susceptible strain 0.032 mg/L. Likewise, the MPC of enrofloxacin for the susceptible strain was 0.512 mg/L (corresponding to a 16-fold increase in comparison with the MIC), while the MPC for the resistant strains was 1024 mg/ L ( Figure 1 . Schematic plan of the experiments (same for each experiment performed). As soon as the chicks were hatched, they were inoculated with a specific bacterial inoculum according to the experiment performed. Each stable contained a control group (non-treated animals), a group that was treated with Baytril TM 2.5% injectable solution intramuscularly and a group that received oral treatment (Baytril TM 10% oral solution). Treatment period lasted 3 days (days 6-8). Treatment started right after the second sampling took place. Treatment dose schemes (stable 1, proper-dose; stable 2, half-dose; stable 3, double-dose) were calculated based on the recommended therapeutic protocol of the company (Bayer AG). Drinking water medication was prepared daily. One sampling every 3 days until day 15. Then, one additional sampling took place right before euthanasia on day 22.
1 TD, treatment dose; SD, sampling day. i.m., intramuscular; p.o., oral.
chromatography-tandem MS method for the quantification of enrofloxacin in the intestinal content of broiler chickens was described. There it was shown that after the administration of 10 mg/kg enrofloxacin (oral and intramuscular), the intestinal microbiota in the caecum and colon was exposed to significant levels of enrofloxacin (21-130 lg/g). Therefore, it can be assumed that in the in vivo experiments of the present study, the gut concentrations of enrofloxacin were much higher than the MPC of the susceptible strain. Although selection for additional resistance in the susceptible strain cannot be excluded, the observed changes in the proportions of susceptible and resistant strains were interpreted as being the result of the multiplication of the already present (inoculation) resistant or susceptible stains. Consequently, the effects described are caused by resistance selection rather than by the emergence of new resistance. This is further supported by the fact that the enrofloxacin resistance of the resistant strain is located in the chromosome (non-mobile), indicating that only the fluoroquinolone-resistant strains were spreading under the selection pressure of the treatment (MIC value of 32 mg/L). Inclusion of a control group inoculated with a fully fluoroquinolone-susceptible inoculum would have provided further information on the selection for additional resistance in the susceptible strain, but due to limitations of the experimental set-up, this was not feasible.
Phenotyping of E. coli from in vivo experiments
No animal showed any signs of disease throughout the duration of the experiments. The E. coli strains that were used successfully colonized the gastrointestinal tract of the animals ( Figures  2-5) . In several studies examining the gastrointestinal microbiota of hatched chickens, 50, 51 it has been found that after reaching optimal growth within the first 2 days of life, the E. coli population decreased rapidly at 8-9 days and was hardly found at 14 days. Hence, while the very young chick is quite a good and permissive host for E. coli, 52 it is quickly colonized by other types of bacteria. Although this decline was also observed in the present in vivo experiments (data not shown), a sufficient number of E. coli colonies were nevertheless retrieved in the majority of the samples until the end of the experiment, thus allowing for full evaluation of the effect. Only in Experiment 2, on the last sampling day and for the samples from orally treated animals (half dose group: 5 mg/kg), were no E. coli cfu found on the McConkey plates (Figure 3) .
A study of the data from the control groups of all four experiments (Figures 2-5 ) revealed significant differences between the experiments. These differences, which were due to the different inocula used, were verified by statistical analysis (P , 0.001). However, no significant difference (P " 0.304) was found between the control groups over time, indicating that within each experiment the control groups behaved relatively alike. This indicates that likely no cross-contamination occurred between the treated and the control groups, which suggests that the experimental set-up worked.
Effect of strain in the absence of treatment
The results from all non-treated animals ( Figures 3 and 4) show that the animals that were inoculated either with a 100:1 ratio of the fit resistant/fit susceptible strain (Experiment 2) or with the opposite ratio (1:100) (Experiment 3) did not show any signs of reversion of antimicrobial resistance towards susceptibility, which suggests that for this strain there appears not to be a fitness cost due to resistance. This finding is in agreement with findings of in vitro 53 and in vivo 54 mutational resistance studies focusing, respectively, on Mycobacterium spp. and on Campylobacter spp. By contrast, 3 weeks (day 23) after inoculation, the non-fit resistant strain could no longer be isolated from the samples taken from non-treated animals that had been inoculated with the non-fit resistant strain either in a 100:1 (Figure 2 ) or in a 1:100 ( Figure 5 ) ratio.
Effect of treatment
A comparison of the temporal fluctuations of the results from each treated group per experiment (Figures 2-5) shows that there were considerable fluctuations in Experiments 1 and 4. This could be attributed to the reduced fitness of the strain that was predominantly inoculated, since the growth potential of bacteriologically non-fit bacteria is difficult to predict in vivo. Fluoroquinolone resistance in E. coli in poultry JAC resistant strains compared with the respective treated groups ( Table 3) . The results of Experiments 1 and 4 suggest that when animals are inoculated with non-fit strains, treatment resulted in the persistence of a strain that would normally die out before the end of the experiment (no enrofloxacin-resistant E. coli isolates were found on day 22 in all three control groups). The results from Experiment 3 suggest that when the inoculum consists of a small proportion of fit resistant strains, the treatment clearly promotes this fit strain, thus allowing it to become the dominant strain. These results are in agreement with the findings of other studies, 14 ,55 where significant differences in resistance rates persisted between the intestinal E. coli of the enrofloxacin orally treated groups and the non-treated groups.
In contrast, for Experiment 2, the findings from the control and the treated groups were similar up to the end of the experiment (P " 0.313). The inoculum was largely composed of the fit resistant strain, which apparently colonized the gut of the birds successfully and remained prevalent up to the end of the experiment, irrespective of treatment. Accordingly, Austin et al. 56 suggested that once the resistance prevalence reaches a certain level, antimicrobial use no longer plays a role in the resistance selection. Handel et al. 57 reported that small changes in the volumes of antimicrobials used in a population with a low level of antimicrobial resistance lead to much larger changes in resistance when compared with changes in antimicrobials used at a high level of resistance. Similar effects were seen when comparing antimicrobial use with antimicrobial Chantziaras et al.
resistance levels for several classes of antibiotics using data from seven European countries.
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Fitness of the resistant strain and route of administration
All potential effects were tested univariately and the statistically significant effects of strain (P , 0.001) and administration route (P " 0.044) were selected and further included in a multivariate linear mixed model. The factors that were finally selected were bacterial fitness of the resistant strain (P , 0.001) and route of administration (P " 0.052), as well as the interaction between bacterial fitness and administration route (P , 0.001) ( Table 4) . Regarding fitness, the inoculation with a fit resistant strain clearly resulted in significantly higher proportions of resistant E. coli. When comparing the administration routes, oral administration selected more for resistance. When looking at the interactions, it becomes clear that the combination of oral treatment and a non-fit strain had a significantly larger influence on the outcome. No similar studies have been performed for broiler chickens, but in a somewhat comparable study focusing on pigs and using Salmonella enrofloxacinsusceptible and enrofloxacin-resistant strains, 59 selection for resistance among the artificially introduced Salmonella was also higher for oral administration than for intramuscular.
Treatment dose
The treatment dose did not result in significant differences (P " 0.764) with regard to the resistance ratio. This is in agreement with Jurado et al., 14 who found no significant differences among different enrofloxacin dosage schemes that were administered orally to broiler chickens. Although various studies showed that dosage can have an effect on the emergence of resistance, 34, 35, 60, 61 the results of the present study suggest that it does not have an effect on the selection and spread of resistance. Grouping the referred studies with regards to commensal versus pathogenic E. coli isolates, the mutation frequencies of the strains were compared. The mutation frequencies of pathogenic E. coli isolates resulted mostly in MPC/MIC ratios of 8 or 16 34 
For the needs of the statistical models each animal was listed as subject, and sampling as repeated. The repeated covariance type was first-order autoregressive. Dependent variable used was the proportion of the enrofloxacin-resistant colonies to the sum of the resistant and the susceptible colonies.
Fluoroquinolone resistance in E. coli in poultry JAC comparable to the mutation frequencies of commensal E. coli isolates-including those in this study (ratio of 16). However, it must be noted that the phenomenon of emergence of resistance was not studied in the current in vivo experiments. De novo resistance mutations could not be assessed in this study design because no fully susceptible inoculum was included.
In accordance with the EMA guidelines, we used the most commonly recommended dose for chickens and turkeys (10 mg enrofloxacin/kg bodyweight per day for 3-5 consecutive days), and, based on this, we calculated the half and the double dose. However, this dose range does not cover the full range of doses available in leaflets across Europe (from 2.5 to 20 mg/kg, from 2 to 10 days), albeit for different animal species and indications. 63 We selected the current dose variation as a starting point for assessing the effect of dosing because deviations from doses below the authorized dosages, together with plasmid-mediated resistance, have been found to enhance resistance. [64] [65] [66] Final remarks and further use
The use of isogenic strains allowed for direct comparisons between all in vivo experiments since differences between the fit and non-fit strains can be attributed to the point mutations leading to resistance. To our knowledge, this is the first time such in vivo experiments have been performed to measure selection for resistance taking into account the prevalence of enrofloxacin resistance in the initial gut microbiota, bacterial fitness of the resistant strain, route of administration and treatment dose. However, the results could have been different if a strain carrying PMQR genes had been used. Although these genes are quite rare in commensal E. coli strains isolated from chickens, 67-69 the transfer rate of resistance is expected to be higher in the presence of such plasmids. 70 Phenomena such as plasmid loss 71 and plasmid incompatibility 72 should also be considered. The WT strain did not show increased MICs of enrofloxacin. The enrofloxacin-resistant strain was created in vitro via a chromosomal mutation of the parental WT strain. In vivo, we took all necessary biosecurity measures to prevent the introduction of other strains (via feed, water, airborne, etc.). Given the fact that the ratio of the resistant strains in the control groups after treating the other groups was not affected (in favour of the resistant strains) in any group and in any experiment, this provided an in vivo illustration of the effectiveness of the experimental setting. Thus, the presence of PMQR genes was ruled out.
Overall, the experimental set-up made it possible to study and assess several effects concerning the selection of fluoroquinolone resistance. This study provides a basis for selecting and further investigating relevant research topics. By studying the benefits and After assessing univariately the main effects of strain, prevalence of resistance before treatment (inoculum ratio), treatment dose and administration route, a multivariate model tested the effects of fitness of the strain and administration route. In the final mixed linear model, two-way interactions between significant variables were also evaluated (with the significance level set at P , 0.05). In all models, to correct for the interdependency of chicks within a pen, pen was included as a random variable.
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the limitations of each experiment, one could select the appropriate experimental setting in accordance with the specific research question. For example, one study set-up could be selected to focus on treatment effect and its administration patterns (use of non-fit enrofloxacin-resistant strain, oral administration of enrofloxacin and test various treatment schemes), a different set-up could focus on the selection of antimicrobial resistance (treated animals, use of bacteriologically fit enrofloxacin-resistant strains and testing inocula of increasing prevalence), and a third set-up could focus on characteristics of reversion of antimicrobial resistance (non-treated animals inoculated with strains of different bacteriological fitness and testing for reversibility of antimicrobial resistance).
Conclusions
For the purposes of this study, a standardized in vivo model was developed that can be used to investigate resistance selection in commensal E. coli in poultry. Gut colonization with a bacteriologically fit enrofloxacin-resistant strain and oral administration of enrofloxacin selected more for antimicrobial resistance than colonization with a non-fit resistant strain and parenteral treatment respectively. This novel protocol made it possible to study various factors both selectively and collectively, and to identify the advantages and disadvantages in each case, thus providing insights into treatment strategies using enrofloxacin.
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